Beijing Genomics Institute (BGI) Shenzhen Plans IPO

Published: Sep 03, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

September 3, 2013 -- BGI Shenzhen, the world’s largest sequencing company, is planning to split itself in two and IPO its institutional sequencing business. The other half, its “retail” diagnostic sequencing segment, which serves the hospital/clinic market, will remain private. BGI hasn’t officially announced its IPO, so no financial details for the transaction are available, nor has the company named its target exchange. More details....

Help employers find you! Check out all the jobs and post your resume.

Back to news